Y-mAbs Therapeutics Board Member Dr. Ber Announces Resignation
Company Announcements

Y-mAbs Therapeutics Board Member Dr. Ber Announces Resignation

Y-Mabs Therapeutics (YMAB) has issued an announcement.

Gérard Ber, Ph.D., has announced his resignation from the Board of Directors of Y-mAbs Therapeutics, effective June 10, 2024. The departure is amicable, with no disagreements over operations, policies, or practices cited. Dr. Ber will continue to offer his expertise to the company in a consultative capacity post-resignation, and the company has expressed gratitude for his dedication and service.

Learn more about YMAB stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskY-mAbs Reports Third Quarter 2024 Financial Results
TheFlyMorning Movers: Expedia, Airbnb moving in opposite directions after results
TheFlyY-mAbs Therapeutics reports Q3 EPS (16c), consensus (16c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App